Most recovery products address inflammation through a single pathway
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 10% by weight of the carbomer
Besides counteraction of bleeding aspirin-gastric ulcers (14), BPC 157 also counteracts other NSAIDs-toxicity, using the same dose range (8-14), namely, gastric and small intestine ulcers (i.e., induced by indomethacin, diclofenac, ibuprofen, celecoxib (8-14)), hepatotoxicity (paracetamol, diclofenac, ibuprofen, celecoxib) (8-14) and encephalopathy (paracetamol, diclofenac, ibuprofen, celecoxib) (8-14)
If you're ready to improve recovery and get back to doing the activities you enjoy, schedule a consultation with our team to learn whether peptide therapy may be right for you
Such small actions prevent contamination that could compromise safety